Esperion Therapeutics, Inc.
GB ˙ LSE ˙ US29664W1053
3,13 $ ↓ -0,00 (-0,04%)
2026-06-04
DEL PRIS
SecurityGB:0IIM / Esperion Therapeutics, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership93,492 shares
Latest Disclosed Value $ 256,168
Creative Planning ownership in 0IIM / Esperion Therapeutics, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 93,492 shares of Esperion Therapeutics, Inc. (GB:0IIM) valued at $254,121 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 117,367 shares of Esperion Therapeutics, Inc.. This represents a change in shares of -20.34% during the quarter. The current value of the position is $292,630 USD.

Creative Planning has a history of taking positions in derivatives of the underlying security (0IIM) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

GB:0IIM / Esperion Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 93,492 -23,875 -20.34 256 -41.01 0.0002
2026-02-17 2025-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 117,367 67,454 135.14 434 228.79 0.0003
2025-11-14 2025-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 49,913 49,913 132 0.0001
2025-05-15 2025-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -34,989 -100.00 0 -100.00
2025-02-14 2024-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 34,989 11,756 50.60 77 100.00 0.0001
2024-10-11 2024-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 23,233 2,636 12.80 38 -15.56 0.0000
2024-08-15 2024-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 20,597 20,597 46 0.0000
2024-02-14 2023-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -100 -100.00 0 0.0000
2023-11-16 2023-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 100 100 0 0.0000
2020-05-05 2020-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -7,876 -100.00 0 -100.00
2020-01-30 2019-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 7,876 0 0.00 470 62.63 0.0014
2019-11-01 2019-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 7,876 -235 -2.90 289 -23.34 0.0009
2019-07-26 2019-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 8,111 -19,493 -70.62 377 -65.97 0.0013
2019-04-24 2019-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 27,604 19,755 251.69 1,108 206.93 0.0040
2019-02-12 2018-12-31 13F/A-1 ESPERION THERAPEUTICS INC NE COM 29664W105 7,849 287 3.80 361 7.44 0.0015
2019-02-01 2018-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 7,849 287 361
2018-10-25 2018-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 7,562 2,236 41.98 336 60.77 0.0012
2018-07-20 2018-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 5,326 -10,110 -65.50 209 -81.27 0.0008
2018-04-18 2018-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 15,436 10,660 223.20 1,116 255.41 0.0045
2018-01-17 2017-12-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 4,776 4,776 314 0.0014
2017-10-17 2017-09-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 0 -3,100 -100.00 0 -100.00
2017-07-12 2017-06-30 13F ESPERION THERAPEUTICS INC NE COM 29664W105 3,100 -1 -0.03 143 31.19 0.0007
2017-04-07 2017-03-31 13F ESPERION THERAPEUTICS INC NE COM 29664W105 3,101 3,101 109 0.0006
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-07-12 2017-06-30 13F ESPERION THERAPEUTICS INC NE COM Call 0 -100.00 0 n/a n/a n/a
2017-04-07 2017-03-31 13F ESPERION THERAPEUTICS INC NE COM Call 200 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.